Vancocin HCL In Plastic Container en es it fr

Vancocin HCL In Plastic Container Brand names, Vancocin HCL In Plastic Container Analogs

Vancocin HCL In Plastic Container Brand Names Mixture

  • No information avaliable

Vancocin HCL In Plastic Container Chemical_Formula

C18H22O4

Vancocin HCL In Plastic Container RX_link

No information avaliable

Vancocin HCL In Plastic Container fda sheet

Vancocin HCL In Plastic Container msds (material safety sheet)

Vancocin_HCL_In_Plastic_Container MSDS

Vancocin HCL In Plastic Container Synthesis Reference

No information avaliable

Vancocin HCL In Plastic Container Molecular Weight

302.365 g/mol

Vancocin HCL In Plastic Container Melting Point

185.5 oC

Vancocin HCL In Plastic Container H2O Solubility

No information avaliable

Vancocin HCL In Plastic Container State

Solid

Vancocin HCL In Plastic Container LogP

4.018

Vancocin HCL In Plastic Container Dosage Forms

Cream (10%)

Vancocin HCL In Plastic Container Indication

Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated).

Vancocin HCL In Plastic Container Pharmacology

Masoprocol is a novel antineoplastic agent. It is not known exactly how masoprocol works. Laboratory experiments have shown that masoprocol prevents cells similar to the ones found in actinic keratoses from multiplying. Masoprocol was withdrawn from the U.S. market in June 1996.

Vancocin HCL In Plastic Container Absorption

Less than 1%-2% is absorbed through the skin over a 4-day period following application.

Vancocin HCL In Plastic Container side effects and Toxicity

Symptoms of overdose or allergic reaction include bluish coloration of skin, dizziness, severe, or feeling faint, wheezing or trouble in breathing.

Vancocin HCL In Plastic Container Patient Information

No information avaliable

Vancocin HCL In Plastic Container Organisms Affected

Humans and other mammals